310 related articles for article (PubMed ID: 15110319)
21. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of oxidation from phytol to phytanic acid in man.
Wierzbicki AS
Mol Genet Metab; 2004 Dec; 83(4):347. PubMed ID: 15589124
[No Abstract] [Full Text] [Related]
23. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
24. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
25. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
Xu F; Ng VY; Kroetz DL; de Montellano PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
[TBL] [Abstract][Full Text] [Related]
27. Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA.
Verhoeven NM; Schor DS; ten Brink HJ; Wanders RJ; Jakobs C
Biochem Biophys Res Commun; 1997 Aug; 237(1):33-6. PubMed ID: 9266824
[TBL] [Abstract][Full Text] [Related]
28. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
Rizzo WB; Lin Z; Carney G
Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
[TBL] [Abstract][Full Text] [Related]
29. The Refsum disease marker phytanic acid, a branched chain fatty acid, affects Ca2+ homeostasis and mitochondria, and reduces cell viability in rat hippocampal astrocytes.
Kahlert S; Schönfeld P; Reiser G
Neurobiol Dis; 2005 Feb; 18(1):110-8. PubMed ID: 15649701
[TBL] [Abstract][Full Text] [Related]
30. A study of the cytotoxicity of branched-chain phytanic acid with mitochondria and rat brain astrocytes.
Schönfeld P; Kahlert S; Reiser G
Exp Gerontol; 2006 Jul; 41(7):688-96. PubMed ID: 16616447
[TBL] [Abstract][Full Text] [Related]
31. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
Rizzo WB; Carney G
Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
[TBL] [Abstract][Full Text] [Related]
32. Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease.
Krauß S; Michaelis L; Vetter W
PLoS One; 2017; 12(11):e0188035. PubMed ID: 29131855
[TBL] [Abstract][Full Text] [Related]
33. Peroxisomal trans-2-enoyl-CoA reductase is involved in phytol degradation.
Gloerich J; Ruiter JP; van den Brink DM; Ofman R; Ferdinandusse S; Wanders RJ
FEBS Lett; 2006 Apr; 580(8):2092-6. PubMed ID: 16546181
[TBL] [Abstract][Full Text] [Related]
34. Brain pyruvate and 2-oxoglutarate dehydrogenase complexes are mitochondrial targets of the CoA ester of the Refsum disease marker phytanic acid.
Bunik VI; Raddatz G; Wanders RJ; Reiser G
FEBS Lett; 2006 Jun; 580(14):3551-7. PubMed ID: 16737698
[TBL] [Abstract][Full Text] [Related]
35. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
36. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
Auada MP; Taube MB; Collares EF; Tanaka AM; Cintra ML
Eur J Dermatol; 2002; 12(3):263-6. PubMed ID: 11978568
[TBL] [Abstract][Full Text] [Related]
37. The metabolic basis of the Refsum syndrome.
Steinberg D
Birth Defects Orig Artic Ser; 1971 Feb; 7(1):42-52. PubMed ID: 4141910
[TBL] [Abstract][Full Text] [Related]
38. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
[TBL] [Abstract][Full Text] [Related]
39. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes.
Rönicke S; Kruska N; Kahlert S; Reiser G
Neurobiol Dis; 2009 Nov; 36(2):401-10. PubMed ID: 19703563
[TBL] [Abstract][Full Text] [Related]
40. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Rizzo WB
Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
